Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 25, 2017

DrugPatentWatch Database Preview

Eszopiclone - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for eszopiclone and what is the scope of eszopiclone freedom to operate?

Eszopiclone
is the generic ingredient in two branded drugs marketed by Sun Pharma Global, Orchid Hlthcare, Dr Reddys Labs Ltd, Lupin Ltd, Macleods Pharms Ltd, Aurobindo Pharma Ltd, Mylan Pharms Inc, West-ward Pharms Int, Wockhardt Ltd, Glenmark Generics, Teva, and Sunovion Pharms Inc, and is included in twelve NDAs. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for eszopiclone. Thirty-seven suppliers are listed for this compound.

Summary for Generic Name: eszopiclone

Tradenames:2
Patents:1
Applicants:12
NDAs:12
Drug Master File Entries: see list20
Suppliers / Packagers: see list37
Bulk Api Vendors: see list44
Clinical Trials: see list13
Patent Applications: see list1,625
Therapeutic Class:Sedatives/Hypnotics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:eszopiclone at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Macleods Pharms Ltd
ESZOPICLONE
eszopiclone
TABLET;ORAL202929-001Jan 30, 2015ABRXNoNo► Subscribe► Subscribe
Orchid Hlthcare
ESZOPICLONE
eszopiclone
TABLET;ORAL091113-002Jun 10, 2014ABRXNoNo► Subscribe► Subscribe
Glenmark Generics
ESZOPICLONE
eszopiclone
TABLET;ORAL091166-002Apr 15, 2014ABRXNoNo► Subscribe► Subscribe
Glenmark Generics
ESZOPICLONE
eszopiclone
TABLET;ORAL091166-001Apr 15, 2014ABRXNoNo► Subscribe► Subscribe
Macleods Pharms Ltd
ESZOPICLONE
eszopiclone
TABLET;ORAL202929-003Jan 30, 2015ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Formulary management
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot